Alembic Pharmaceuticals Fair Value
Alembic Pharmaceuticals (APLLTD) average fair value is ₹1332.83 across 7 valuation models — P/E Based Valuation, P/B Based Valuation, Dividend Discount Model, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹821.75 (+62.19%), fair value range ₹202.04–₹5719.88. For live price and a broader fundamental view, visit Alembic Pharmaceuticals screener.
Fair Value Analysis Export
APLLTD Fair Value vs Current Price — Valuation Summary
APLLTD average fair value, fair value range, price gap and valuation status across 7 models: P/E Based Valuation, P/B Based Valuation, Dividend Discount Model, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). Explore APLLTD Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.
P/E Based Valuation
P/B Based Valuation
Dividend Discount Model
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
APLLTD Fair Value Analysis — Data Sources & Coverage
Alembic Pharmaceuticals financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. Review APLLTD earnings valuation to evaluate earnings-based valuation against sector peers.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
APLLTD vs Healthcare Sector Peers — P/E, P/B & Market Cap
Alembic Pharmaceuticals P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Syngene International | SYNGENE | 73.72 | 3.36 | ₹16,433 |
| Jeena Sikho Lifecare | JSLL | 27.19 | 13.76 | ₹6,314 |
| Kerala Ayurveda | KERALAYUR | -7.9 | 18.27 | ₹225 |
| Sat Kartar Life | SATKARTAR | 11.18 | 2.79 | ₹184 |
| Divis Laboratories | DIVISLAB | 77.15 | 13.46 | ₹225,157 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.